{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T13:04:54Z","timestamp":1648904694498},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T00:00:00Z","timestamp":1380240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00059-013-3941-9","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T12:01:18Z","timestamp":1380110478000},"page":"889-900","source":"Crossref","is-referenced-by-count":0,"title":["Management des akuten ST-Strecken-Hebungsinfarktes"],"prefix":"10.1007","volume":"38","author":[{"given":"S.","family":"Birkmeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,27]]},"reference":[{"key":"3941_CR1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurheartj\/ehp492","volume":"31","author":"Widimsky","year":"2010","unstructured":"Widimsky P, Wijns W, Fajadet J de et al (2010) Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 31:943\u2013957","journal-title":"Eur Heart J"},{"key":"3941_CR2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjmed.2010.07.023","volume":"124","author":"McManus","year":"2011","unstructured":"McManus DD, Gore J, Yarzebski J et al (2011) Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med 124:40\u201347","journal-title":"Am J Med"},{"key":"3941_CR3","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"Task","year":"2012","unstructured":"Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569\u20132619","journal-title":"Eur Heart J"},{"key":"3941_CR4","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","volume":"33","author":"Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. Eur Heart J 33:2551\u20132567","journal-title":"Eur Heart J"},{"key":"3941_CR5","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1001\/jama.293.23.2865","volume":"293","author":"Sch\u00f6mig","year":"2005","unstructured":"Sch\u00f6mig A, Mehilli J, Antoniucci D et al (2005) Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 293:2865\u20132872","journal-title":"JAMA"},{"key":"3941_CR6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/eurheartj\/ehq410","volume":"32","author":"Widimsky","year":"2011","unstructured":"Widimsky P, Holmes DR (2011) How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J 32:396\u2013403","journal-title":"Eur Heart J"},{"key":"3941_CR7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjcard.2009.04.016","volume":"104","author":"Cavender","year":"2009","unstructured":"Cavender MA, Milford-Beland S, Roe MT et al (2009) Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). Am J Cardiol 104:507\u2013513","journal-title":"Am J Cardiol"},{"key":"3941_CR8","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2012.06.017","volume":"60","author":"Romagnoli","year":"2012","unstructured":"Romagnoli E, Biondi-Zoccai G, Sciahbasi A et al (2012) Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol 60:2481\u20132489","journal-title":"J Am Coll Cardiol"},{"key":"3941_CR9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(11)60404-2","volume":"377","author":"Jolly","year":"2011","unstructured":"Jolly SS, Yusuf S, Cairns J et al (2011) Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 377:1409\u20131420","journal-title":"Lancet"},{"key":"3941_CR10","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehm402","volume":"28","author":"Kastrati","year":"2007","unstructured":"Kastrati A, Dibra A, Spaulding C et al (2007) Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 28:2706\u20132713","journal-title":"Eur Heart J"},{"key":"3941_CR11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jcin.2011.11.009","volume":"5","author":"Wijnbergen","year":"2012","unstructured":"Wijnbergen I, Helmes H, Tijssen J et al (2012) Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study. JACC Cardiovasc Interv 5:313\u2013322","journal-title":"JACC Cardiovasc Interv"},{"key":"3941_CR12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(09)62001-8","volume":"375","author":"B\u00f8tker","year":"2010","unstructured":"B\u00f8tker HE, Kharbanda R, Schmidt MR et al (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375:727\u2013734","journal-title":"Lancet"},{"key":"3941_CR13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"Thiele","year":"2012","unstructured":"Thiele H, Zeymer U, Neumann F-J et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367:1287\u20131296","journal-title":"N Engl J Med"},{"key":"3941_CR14","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"3941_CR15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","volume":"373","author":"Montalescot","year":"2009","unstructured":"Montalescot G, Wiviott SD, Braunwald E et al (2009) Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 373:723\u2013731","journal-title":"Lancet"},{"key":"3941_CR16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045\u20131057","journal-title":"N Engl J Med"},{"key":"3941_CR17","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","volume":"122","author":"Steg","year":"2010","unstructured":"Steg PG, James S, Harrington RA et al (2010) Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation 122:2131\u20132141","journal-title":"Circulation"},{"key":"3941_CR18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","volume":"381","author":"Dewilde","year":"2013","unstructured":"Dewilde WJM, Oirbans T, Verheugt FWA et al (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381:1107\u20131115","journal-title":"Lancet"},{"key":"3941_CR19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(09)61484-7","volume":"374","author":"Mehran","year":"2009","unstructured":"Mehran R, Lansky AJ, Witzenbichler B et al (2009) Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 374:1149\u20131159","journal-title":"Lancet"},{"key":"3941_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcin.2009.11.012","volume":"3","author":"Montalescot","year":"2010","unstructured":"Montalescot G, Ellis SG, Belder MA de et al (2010) Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). JACC Cardiovasc Interv 3:203\u2013212","journal-title":"JACC Cardiovasc Interv"},{"key":"3941_CR21","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1136\/bmj.e553","volume":"344","author":"Silvain","year":"2012","unstructured":"Silvain J, Beygui F, Barth\u00e9l\u00e9my O et al (2012) Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ 344:e553","journal-title":"BMJ"},{"key":"3941_CR22","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/j.1538-7836.2011.04445.x","volume":"9","author":"Navarese","year":"2011","unstructured":"Navarese EP, De Luca G, Castriota F et al (2011) Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. J Thromb Haemost 9:1902\u20131915","journal-title":"J Thromb Haemost"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-013-3941-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-013-3941-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-013-3941-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T15:56:41Z","timestamp":1558540601000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-013-3941-9"}},"subtitle":["Update 2013"],"short-title":[],"issued":{"date-parts":[[2013,9,27]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3941"],"URL":"https:\/\/doi.org\/10.1007\/s00059-013-3941-9","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,27]]}}}